BSECompany Update5d ago · 23 Jul 2026, 12:58 pm

Please find enclosed herewith the Notice sent to shareholders w.r.t. the transfer of Unclaimed Final Dividend 2018-2019 and its corresponding shares to the IEPF Authority.

Bliss GVS Pharma Ltd · 506197

✦ AI SummaryDividend

Bliss GVS Pharma Ltd has announced that it will transfer unclaimed dividends and corresponding shares to the Investor Education and Protection Fund (IEPF) Authority as per the Companies Act, 2013 and IEPF Rules. Shareholders who have not claimed dividends for 7 years or more will have their shares transferred to IEPF. Shareholders can prevent this by submitting a written request with required documents to the RTA by October 27, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bliss GVS Pharma Ltd - 506197 - Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend 2018-2019 And Its Corresponding Shares To Investor Education And Protection Fund (IEPF) Authority

Attachments (1)

📄

7f115f5b-ce62-4b55-bbf7-4af867814849.pdf

pdf

Download →
View document text
July 23, 2026 To To The Manager, Listing Department The General Manager, Listing National Stock Exchange of India Department Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Notice to Shareholders w.r.t. transfer of unclaimed Final Dividend 2018-2019 and its Corresponding Shares to Investor Education and Protection Fund (IEPF) Authority In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a copy of the communication sent to those concerned shareholders, whose dividends have remained unclaimed for a period of seven consecutive years or more, concerning the proposed transfer of unclaimed final dividend 2018-2019 and its corresponding shares to the IEPF Authority in pursuance of section 124(6) of the Companies Act, 2013 read with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016. You are requested to take the above on record. Thanking you. For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary Encl: a/a BLISS GVS PHARMA LIMITED 102, Hyde Park, Saki Vihar Road, Andheri (East) Mumbai - 400 072. Tel: 022-42160000 Fax: 022-28563930; Email: info@blissgvs.com/ cs@blissgvs.com Website : www.blissgvs.com CIN: L24230MH1984PLC034771 Sr No.: xx Date : July 21,2026 Name of the Shareholder: xxxxx Folio No./DP ID & Client ID : xxxxxx Address: xxxxxxxxxxxx Dear Shareholder(s), Subject: Compulsory transfer of Equity Shares of the Company relating to unclaimed Final Dividend for the year 2018-19 to Investor Education and Protection Fund Authority (‘IEPF Authority’) As you are aware, the dividend declared by the Company is remitted either electronically or by sending dividend warrants to the registered address of the eligible shareholders. In case any dividend remains unpaid/unclaimed, the Company has reminded periodically to such shareholders to claim such dividend. As per Section 124(5) of the Companies Act, 2013, any dividend remaining unpaid/unclaimed for a period of 7 (Seven) years is required to be transferred by the Company to the Investor Education and Protection Fund (‘IEPF’) established by the Central Government. The Company has regularly uploaded full details of such unpaid or unclaimed dividends before transferring to IEPF on its website and on the website of the Ministry of Corporate Affairs, Government of India. Further, Section 124(6) requires that all shares in respect of which unpaid/unclaimed dividend for a period of 7 (Seven) years shall be transferred to IEPF. Ministry of Corporate Affairs has notified Investors Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 which came into force on September 07, 2016, and has been further amended by Investors Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Amendment Rules, 2017 with effect from February 28, 2017. The said Rules, amongst other matters, contain provisions for the transfer of all shares in respect of which dividend has not been paid/claimed for seven consecutive years or more, in favour of Investor Education & Protection Fund Authority. As per our records, the following dividends which were issued/remitted in your name in the last seven years remained unpaid/unclaimed: Financial year ended Date of declaration of dividend Dividend Warrant No. Dividend Amount (Rs.) Final Dividend for the Year 2018-2019 September 20, 2019 Final Dividend for the Year 2019-2020 September 25, 2020 Final Dividend for the Year 2020-2021 September 21, 2021 Final Dividend for the Year 2021-2022 June 28, 2022 Final Dividend for the Year 2022-2023 July 19, 2023 Final Dividend for the year 2023-2024 July 25, 2024 Final Dividend for the year 2024-2025 July 25, 2025 Interim Dividend for the year 2025-2026 February 10, 2026 The final dividend for the financial year 2017-2018 has already been transferred to the Investor Education & Protection Fund as per the erstwhile IEPF Rules. As per the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Amendment Rules, 2017, the shares in respect of which dividend has not been paid or claimed for seven consecutive years or more shall be transferred by the Company in favour of IEPF Authority after giving notice to such shareholders. Accordingly, all your shares (whether held in physical or electronic form) for which you have not claimed the final dividend for the financial year 2018-2019 onwards will be transferred as per the said rules by the Company to IEPF Authority on or after October 27, 2026, from the date of this notice. To stop the credit of shares to IEPF Authority you may forward to RTA a written request letter along with the following documents on or before October 27, 2026: 1. Duly signed letter for claiming the shares (ensure to mention Folio No. or DP ID/Client ID) 2. Self-attested copy of PAN Card. 3. Self-attested copy of residence proof (Vote ID / Aadhar Card / Passport /Driving License) 4. Cancelled Blank Cheque leaf of your bank account. 5. Signature attestation letter from bank manager with Seal of the Bank and Employee ID of attesting authority. 6. And updated Client Master list in case of shares held in Demat mode. As per the above-mentioned Rules, the shares held in physical form are liable to be transferred to IEPF Authority, by issuing duplicate share certificates and upon issue of such duplicate share certificates, the original share certificates(s) which stand registered in your name shall be deemed cancelled and non-negotiable. In case shares are held in demat form and are liable to be transferred to IEPF Authority, the Company shall give instructions to the Depositories through corporate actions for the transfer of shares to IEPF Authority. You may further note that after the transfer of shares to IEPF, any corporate benefit arising out of your shareholding in the Company shall also be credited in favour of IEPF Authority. Please note that no claim shall lie against the Company/ RTA in respect of unclaimed dividend amount and shares transferred to IEPF pursuant to the said Rules. Upon transfer of shares to IEPF, Shareholders can claim the shares from the IEPF authority only by filing the e-form IEPF-5. For claiming such shares, the shareholders are required to follow the procedure as prescribed under the said Rules and available on the website of the IEPF authority i.e. www.iepf.gov.in. Further, considering recent amendments made by SEBI for shareholders holding shares in physical form regarding mandatory registration of their KYC details and Nomination, in case your KYCs are pending, you are requested to kindly submit below-mentioned forms along with the necessary documents at the earliest to the Company: a. Form ISR-1 – Registration of PAN, KYC details, BANK, Mobile No & Email-ID change/updation thereof. b. Copy of PAN and Aadhaar Card of Shareholder(s) (Self-Attested with Date) c. Form ISR-2 – Signature Verification by Banker and 1 Cancelled Cheque Leaf. d. Form SH-13 – Registration of Nominee or Form ISR-3 – Declaration for Opting-out of Nomination These forms are available on the website of the Company at www.blissgvs.com or https://web.in.mpms.mufg.com/KYC-downloads.html Please note that if original share certificates are not in your custody or in case of transmission of shares and issue of duplicate share certificates the Shareholders/Nominee/Legal Heirs may kindly contact the undersigned for necessary actions. Please feel free to contact the Company/Registrar of Transfer Agent in case you have any queries at the following address/email/telephone number: Company Registrar Bliss GVS Pharma Limited MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited) 102, Hyde Park, Saki Vihar Road Andheri (East), Mumbai - 400 [Showing first 8,000 characters — download PDF for full document]